Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giunti Psychometrics Holding SpAFRA:0ZD 13 ROC (Joel Greenblatt) % is 247.95% as of Dec. 2025, which is 36% below its 10-year median of 385.78. GuruFocus rates FRA:0ZD with a GF Score™ of 13/100. Among 838 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks better than 99.16% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Giunti Psychometrics Holding SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 247.95%.
The historical rank and industry rank for Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:0ZD'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 247.95 Med: 385.78 Max: 523.6
Current: 247.95
During the past 2 years, Giunti Psychometrics Holding SpA's highest ROC (Joel Greenblatt) % was 523.60%. The lowest was 247.95%. And the median was 385.78%.
FRA:0ZD's ROC (Joel Greenblatt) % is ranked better than 99.16% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.62
vs FRA:0ZD: 247.95
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0ZD vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giunti Psychometrics Holding SpA ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is one times the annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 247.95% mean?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a ROC (Joel Greenblatt) % of 247.95% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Giunti Psychometrics Holding SpA and its competitors. This is 36% below median its historical median of 385.78. Over the past decade, Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % has ranged from 247.95 to 523.60. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #7 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 0.8%.
Is Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % too high?
Giunti Psychometrics Holding SpA's current ROC (Joel Greenblatt) % of 247.95% is 36% below median its 10-year median of 385.78. Over the past 10 years, this metric has ranged from a low of 247.95 to a high of 523.60. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.62. Giunti Psychometrics Holding SpA's value of 247.95% is 5266.9% above this industry median. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #7 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #7 out of 838 companies for ROC (Joel Greenblatt) %. This places Giunti Psychometrics Holding SpA in the top 1% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.62. Giunti Psychometrics Holding SpA's value of 247.95% is 5266.9% above this benchmark. Historically, Giunti Psychometrics Holding SpA's own ROC (Joel Greenblatt) % has ranged from 247.95 to 523.60 over the past decade. While the company's 10-year median is 385.78 vs. the industry median of 4.62, Giunti Psychometrics Holding SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.62, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giunti Psychometrics Holding SpA's current ROC (Joel Greenblatt) % of 247.95% is 5266.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current ROC (Joel Greenblatt) % is 247.95%, which is 36% below median its own 10-year median of 385.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a current ROC (Joel Greenblatt) % of 247.95%. The current ROC (Joel Greenblatt) % is 247.95%, which is 36% below median its 10-year median of 385.78 and 5266.9% above the Medical Devices & Instruments industry median of 4.62. Giunti Psychometrics Holding SpA's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (FRA:0ZD), the current ROC (Joel Greenblatt) % is 247.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score
Get the complete analysis for FRA:0ZD
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0ZD has been successfully added to your 
